Urol. praxi, 2012; 13(2): 56-61

Treatment of BHP in Czech Republic in context guidelines EAU

MUDr.Petr Hušek, MUDr.Jaroslav Pacovský, MUDr.Josef Košina, MUDr.Miloš Broďák, Ph.D.
Urologická klinika FN a LF UK Hradec Králové

Treatment of BHP in Czech republic should be practice by guidelines CUS (Czech Urology Society) or rather EAU (European Association

of Urology). Other treatment can be considered non lege artis.

Keywords: BHP, LUTS, guidelines

Published: March 16, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hušek P, Pacovský J, Košina J, Broďák M. Treatment of BHP in Czech Republic in context guidelines EAU. Urol. praxi. 2012;13(2):56-61.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, N´Dow J, Nordling J, de la Rosettte JJ. Guidelines of the Treatment of Non-neurogenic Male LUTS. European Association of Urology 2011. Go to PubMed...
    2. Novák K. Terapie non-neurogenních poruch mikce u mužů. Urol. Praxi, 2011; 12 (3): 147-151.
    3. Klečka J, Hora M, Běhounek P, Erat V, Stránský P. Současné možnosti léčby mikčních symptomů dolních močových cest. Urol. praxi, 2010; 11 (3): 124-130.
    4. Louda M, Němečková E, Pacovský J, Broďák M, Košina J, Novák I. Četnost operací prostaty u pacientů léčených pro BHP. Ces Urol 2009; 13 (4): 310.
    5. Hanuš M. Benigní hyperplazie prostaty. Léčba vybraných urologických onemocnění - novelizace 2011: 3-6.
    6. Djavan B, Chapple C, Milani S, Marberger M. State of art on the efficacy and tolerability of alpha 1- andrenoreceptor antagonists in patients with lower tract symtoms suggestive of benig prostatic hyperlplasia, Urology 2004; 64: 1081-1088. Go to original source... Go to PubMed...
    7. Roehrborn CG, Marks LS, Center T, et al. Efficacy and safety dutasteride in the four-year treatment of men with benig prostatic hyperplasia. Urology. 2004; 64: 709-715. Go to original source... Go to PubMed...
    8. Hutchinson A, Farmer R, Verhamme K, et al. The efficacy of drugs for the treatment of LUTS/BHP, a study in 6 European countries. Eur Urol 2007; 51 (1): 207-215. Go to original source... Go to PubMed...
    9. Pacovský J. Nykturie - jak ji znáte i neznáte. Urol. prax, 2011; 12 (2): 92-96.
    10. Broďák M, Holub L. Farmakoterapie benigní hyperplazie prostaty - prevence, účinné preparáty, nežádoucí účinky. Ambulantná terapia, 2007, 5 (2): 75-79.
    11. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell - Walsh. Urology 9th ed. Philadelphia: SOUNDERS ELSEVIER, 2007; 2845-2852. ISBN 13: 978-0-8089-2353-4.
    12. Kawaciuk I. Urologie: Druhé vydání. Praha: Galén, 2009. 384-390.
    13. Klečka J, Hora M. Benigní hyperplazie prostaty a současné trendy v léčbě. Urol. prax. 2007; 3: 102-107.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.